Microfluidics Market by Application (Genomics, Proteomics, Capillary Electrophoresis, IVD (POC, Clinical Diagnostics), Drug Delivery, Microreactor, Lab Tests), Component (Chips, Pump, Needle), Material (Polymer, Glass, Silicon) - Global Forecast to 2023
[228 Pages Report] Microfluidics market is valued at 8.28 billion in 2017 and is expected to grow at a CAGR of 22.6% during the forecast period, to reach to USD 27.91 billion by 2023. Base year considered for the report is 2017 and the forecast period includes 2018 to 2023.
Request for Customization to get the global Microfluidics Market forecasts to 2024
The increasing incidence of other major chronic and infectious diseases, coupled with advancements in coagulation tests, blood gas electrolytes, hematology, urine chemistry, and cardiac markers, are creating new avenues for the growth of the microfluidics market. There is a growing demand for the integration of the microfluidics technology in POC diagnostic devices, manufacturing, fluid-handling schemes, and signal-detection procedures. This is further expected to drive the demand for microfluidics technology in the coming years.
Selected Market Dynamics in Microfluidics Market
Rising demand for point-of-care testing
The global POC diagnostics market is expected to showcase a lucrative growth potential (~10%) in the coming years. This is mainly due to the rising prevalence of lifestyle-related and infectious diseases and the increasing preference for home healthcare. In addition, the growing private investments and venture funding for the development of new products, coupled with government support for improving the adoption of POC devices, are supporting the growth of the POC diagnostics market.
The rising incidence and prevalence of various diseases, coupled with product miniaturization and decentralization of healthcare, are the major factors that are expected to offer significant growth opportunities to players operating in the POC diagnostics market. Cancer is a major health concern in modern societies and the second-leading cause of death for geriatrics, globally. According to the National Cancer Institute, the cost of cancer treatment in the US was USD 125 billion in 2010 and is expected to reach USD 158 billion by 2020. According to the World Cancer Research Fund International (WCRFI), in 2012, there were an estimated 14.1 million new cancer cases worldwide; this figure increased to 17.5 million in 2015 and is expected to reach 24 million by 2035. The rising incidence of cancer is expected to increase the uptake of cancer-related diagnostic technologies. The increasing incidence of other major chronic and infectious diseases, coupled with advancements in coagulation tests, blood gas electrolytes, hematology, urine chemistry, and cardiac markers, are creating new avenues for the growth of the POC diagnostics market. This, in turn, is expected to support the growth of the microfluidics market as POC testing is the largest segment of the microfluidics market for in vitro diagnostics.
Incorporation of the microfluidics technology into existing workflows
There are various technical issues faced by end users while incorporating microfluidic devices into existing workflows. Owing to this, the adoption of microfluidics into regularized drug screening and drug discovery processes is limited.
The first microfluidic screening equipment entered the market less than a decade ago. Currently, the microfluidics technology presents significant opportunities for the further miniaturization and integration of instruments and exhibits a potential for greater automation and cost reduction in the drug discovery and development processes. However, even though microfluidics adds value to the process and instruments, it is likely to take about 10 to 15 years before this technology will completely replace conventional macro-scale research instrumentation. Until such a scenario presents itself, the market will witness irregular installments of microfluidic devices owing to which manufacturers will be sidelined by conventional technology providers to some extent.
Objectives of the study
- To define, describe, segment, and forecast the market on the basis of application, component (type & material), and region
- To forecast the size of the microfluidics market in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To provide detailed information regarding the factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall microfluidics market
- To analyze market opportunities for stakeholders and provide details of a competitive landscape for key players
- To track and analyze competitive developments such as joint ventures, alliances, mergers & acquisitions, new product/technology developments, and R&D activities of the leading players in the Industry.
- To profile key players in the microfluidics market and to comprehensively analyze their core competencies
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the microfluidics market and to estimate the size of other dependent submarkets. Various secondary sources such as associations World Health Organization (WHO), Advanced Medical Technology Association (AdvaMed), PharmaAsia Publication, American Association for Clinical Chemistry (AACC), Association of Medical Diagnostics Manufacturers (AMDM), European Diagnostic Manufacturers Association (EDMA), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), European Federation of Pharmaceutical Industries and Associations (EFPIA), International Society of Drug Delivery Sciences and Technology (APGI), directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess the dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:
Audience:
- Microfluidics-based product manufacturers & distributors
- Microfluidic component manufacturers
- Pharmaceutical and diagnostic companies
- Research institutes
- Medical device companies
- Life science companies
- Healthcare institutions (hospitals, medical schools, and outpatient clinics)
- Government associations
- Market research and consulting firms
- Venture capitalists and investors
Scope of the Report:
The research report categorizes the microfluidics market into the following segments and subsegments:
By Application
- In vitro diagnostics
- Point-of-care Testing
- Clinical Diagnostics
- Pharmaceutical research
- Lab analytics
- Proteomic Analysis
- Genomic Analysis
- Cell-based Assay
- Capillary Electrophoresis
- Micropispensing
- Microreaction
- Lab analytics
- Drug Delivery
- Laboratory Testing
- Agro food Testing
- Industrial Testing
- Environmental Testing
By Type
- Microfluidic Chips
- Microfluidic Sensors
- Microfluidic Pumps
- Microneedles
- Other Component (Flow Controller, Temperature controller, connectors, droplet generator, microreactors, and valves)
By Material
- Polymer-based Microfluidics
- Glass-based Microfluidics
- Silicone-based Microfluidics
- Other material-based Microfluidics (Paper, Ceramics, & Metal)
By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific (RoAPAC)
- Latin America
- Middle East and Africa
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of European microfluidics market into the Netherlands, Switzerland, Austria, Belgium, and others
- Further breakdown of the Rest of Asia microfluidics market into Australia, Singapore, Malaysia, New Zealand, and others
Company Information
- Detailed analysis and profiling of additional microfluidics market players (up to 5)
Browse Related Report: Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024
The global microfluidics market is projected to reach USD 27.91 Billion by 2023 from USD 10.06 Billion in 2018, at a CAGR of 22.6%. Rising demand for point-of-care testing due to the rising incidence of chronic infectious diseases, fast returns on investment on the purchase of equipment integrated with microfluidic technology, faster testing and improved portability through microfluidic chip miniaturization, and entry of new players with innovative microfluidics technology & launch of new and advanced products embedded with microfluidics technology are some of the major factors attributed to the growth of the global market during the forecast period. However, there are certain challenges in incorporating the microfluidics technology into existing workflows. This coupled with the presence of complex and time-consuming regulatory standards are the factors restraining the growth of this microfluidics market up to some extent.
This report analyzes the market by application, component, material, and region. Based on application, the market is segmented into in vitro diagnostics, pharmaceutical and life science research, drug delivery, and laboratory testing. By application, In Vitro Diagnostics segment accounted for the largest share of the market in 2017. High prevalence of infectious and lifestyle diseases, relatively lower turnaround times exhibited by POC testing and clinical diagnostics compared to central lab testing methods, rapid rise in aging population, and the introduction of technologically advanced products are some of the key factors attributed to the large share of this market during the forecast period.
By type, the microfluidics component market is segmented into microfluidic chips, microfluidic sensors, micropumps, microneedles, and others. The microfluidic chip segment accounted for the largest share of the microfluidics market in 2017. High demand for POC testing, rising use of personalized medicine, rise in drug discovery and life science research, and high demand for high-speed diagnostics are responsible for the large share of this market.
By material, the microfluidic component market is segmented into polymer-based microfluidics, glass-based microfluidics, silicone-based microfluidics, and other material-based microfluidics. The polymer-based microfluidics accounted for the largest share of the microfluidics market in 2017, owing to its greater preference for polymers as a substrate in microfluidic devices among manufacturers.
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds the largest share of this market in 2017. Compared to Europe and Asia Pacific, North America has various additional advantages such as investment initiatives by the government and presence of high-quality infrastructure for clinical and laboratory research. The rising healthcare and R&D expenditure is one of the key factors driving the growth of the microfluidics market in North America. However, North America is highly regulated with stringent and time-consuming approval processes that are expected to inhibit the growth of the market in North America.
Some of the prominent players in the Microfluidics Market include Danaher (US), Thermo Fisher (US), PerkinElmer (US), Agilent (US), Bio-Rad (US), Becton, Dickinson and Company (US), Roche (Switzerland), Illumina (US), Fluidigm Microfluidics (US), and QIAGEN (Netherlands). Other key players include Dolomite Microfluidics (UK), GYROS PROTEIN TECHNOLOGIES AB (Sweden), Sphere Fluidics (UK), OPKO Health (US), Waters (US), thinXXS Microtechnology (Germany), Abaxis (US), bioMιrieux (France), Abbott (US), Dolomite Microfluidics (UK), Microfluidic ChipShop (Germany), Elveflow (France), Cellix (Ireland), Micronit Microtechnologies (Netherlands), MicroLiquid (Spain), MiniFAB (Australia), uFluidix (Canada), Micralyne (US), and Fluigent (France).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 18)
1.1 Objectives of the Study
1.2 Definition
1.3 Scope of the Study
1.3.1 Markets Covered
1.4 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders
2 Research Methodology (Page No. - 22)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. - 31)
4 Premium Insights (Page No. - 36)
4.1 Growth Potential of the Microfluidics Market
4.2 Asia Pacific Microfluidic Components Market, By Material
4.3 Geographic Growth Opportunities
4.4 By Geography
4.5 Developing vs Developed Countries
5 Market Overview (Page No. - 40)
5.1 Introduction
5.2 microfluidics Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Demand for Point-Of-Care Testing
5.2.1.2 Fast Returns on Investment
5.2.1.3 Faster Testing and Improved Portability Through Microfluidic Chip Miniaturization
5.2.1.4 Entry of New Players and Launch of New and Advanced Products
5.2.2 Restraints
5.2.2.1 Complex and Time-Consuming Regulatory Approval Process
5.2.2.2 Incorporation of Microfluidics Technology Into Existing Workflows
5.2.3 Opportunities
5.2.3.1 Asia as A Key Growth Hotspot
5.2.3.2 Expanding Applications of Drug Delivery Technologies
5.2.3.3 Growing Applications of Microfluidics Technology
5.2.4 Challenge
5.2.4.1 Standardization/Commercialization of Microfluidic Devices
6 Industry Insights (Page No. - 48)
6.1 Introduction
6.2 Industry Trends
6.2.1 Shifting Trend Toward the Adoption of Polymers
6.2.2 Universities Actively Generating Microfluidic Startups and Large Players Acquiring Small Players
6.3 Parent Markets Analysis
6.4 Evolution of Microfluidics Technology in Healthcare
6.5 Value Chain Analysis
6.5.1 Microfluidic Components Procurement Model of Major Players
7 Microfluidics Market, By Application (Page No. - 59)
7.1 Introduction
7.2 in Vitro Diagnostics
7.2.1 Point-Of-Care Testing
7.2.2 Clinical Diagnostics
7.3 Pharmaceutical and Life Science Research
7.3.1 Lab Analytics
7.3.1.1 Proteomic Analysis
7.3.1.2 Genomic Analysis
7.3.1.3 Cell-Based Assays
7.3.1.4 Capillary Electrophoresis
7.3.2 Microdispensing
7.3.3 Microreaction
7.4 Drug Delivery
7.5 Laboratory Testing
7.5.1 Agro Food Testing
7.5.2 Industrial Testing
7.5.3 Environmental Testing
8 Microfluidic Components Market (Page No. - 82)
8.1 Microfluidic Components Market, By Type
8.1.1 Microfluidic Chips
8.1.2 Microfluidic Sensors
8.1.3 Micropumps
8.1.4 Microneedles
8.1.5 Other Components
8.2 Microfluidic Components Market, By Material
8.2.1 Polymer
8.2.2 Glass
8.2.3 Silicon
8.2.4 Other Materials
9 By Region (Page No. - 95)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.6 Middle East & Africa
10 Competitive Landscape (Page No. - 160)
10.1 Overview
10.2 Product Portfolio Matrix
10.3 Competitive Situations and Trends
10.3.1 Product Launches
10.3.2 Partnerships, Agreements, and Collaborations
10.3.3 Acquisitions
10.3.4 Expansions
11 Company Profiles (Page No. - 167)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Danaher Corporation
11.2 Thermo Fisher Scientific
11.3 Perkinelmer
11.4 Agilent Technologies
11.5 Bio-Rad Laboratories
11.6 Becton, Dickinson and Company
11.7 Illumina
11.8 F. Hoffmann-La Roche
11.9 Fluidigm Corporation
11.10 Dolomite Microfluidics
11.11 Qiagen
11.12 Abbott Laboratories
11.13 Biomιrieux
11.14 Microfluidic Chipshop
11.15 Elveflow
11.16 Cellix
11.17 Micronit Microtechnologies
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 217)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details
List of Tables (166 Tables)
Table 1 Impact Analysis: Market Drivers
Table 2 Impact Analysis: Market Restraints
Table 3 Impact Analysis: Market Opportunities
Table 4 Impact Analysis: Market Challenges
Table 5 List of University Startups in the Microfluidics Market
Table 6 By Application, 20162023 (USD Million)
Table 7 Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 8 Market for in Vitro Diagnostics, By Country, 20162023 (USD Million)
Table 9 Market for Point-Of-Care Testing, By Country, 20162023 (USD Million)
Table 10 Market for Clinical Diagnostics, By Country, 20162023 (USD Million)
Table 11 Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 12 Market for Pharmaceutical and Life Science Research, By Country, 20162023 (USD Million)
Table 13 Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 14 Market for Lab Analytics, By Country, 20162023 (USD Million)
Table 15 Market for Proteomic Analysis, By Country, 20162023 (USD Million)
Table 16 Market for Genomic Analysis, By Country, 20162023 (USD Million)
Table 17 Market for Cell-Based Assays, By Country, 20162023 (USD Million)
Table 18 Market for Capillary Electrophoresis, By Country, 20162023 (USD Million)
Table 19 Market for Microdispensing, By Country, 20162023 (USD Million)
Table 20 Microfluidics Market for Microreaction, By Country, 20162023 (USD Million)
Table 21 Market for Drug Delivery, By Country, 20162023 (USD Million)
Table 22 Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 23 Market for Laboratory Testing, By Country, 20162023 (USD Million)
Table 24 Market for Agro Food Testing, By Country, 20162023 (USD Million)
Table 25 Market for Industrial Testing, By Country, 20162023 (USD Million)
Table 26 Market for Environmental Testing, By Country, 20162023 (USD Million)
Table 27 Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 28 Microfluidic Components Market, By Country, 20162023 (USD Million)
Table 29 Microfluidic Chips Market, By Country, 20162023 (USD Million)
Table 30 Microfluidic Sensors Market, By Country, 20162023 (USD Million)
Table 31 Micropumps Market, By Country, 20162023 (USD Million)
Table 32 Microneedles Market, By Country, 20162023 (USD Million)
Table 33 Other Microfluidic Components Market, By Country, 20162023 (USD Million)
Table 34 Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 35 Polymer-Based Microfluidics Market, By Country, 20162023 (USD Million)
Table 36 Glass-Based Microfluidics Market, By Country, 20162023 (USD Million)
Table 37 Silicon-Based Microfluidics Market, By Country, 20162023 (USD Million)
Table 38 Other Material-Based Microfluidics Market, By Country, 20162023 (USD Million)
Table 39 By Region, 20162023 (USD Million)
Table 40 North America: Market, By Country, 20162023 (USD Million)
Table 41 North America: Market, By Application, 20162023 (USD Million)
Table 42 North America: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 43 North America: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 44 North America: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 45 North America: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 46 North America: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 47 North America: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 48 US: Market, By Application, 20162023 (USD Million)
Table 49 US: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 50 US: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 51 US: Microfluidics Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 52 US: Microfluidics Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 53 US: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 54 US: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 55 Canada: Market, By Application, 20162023 (USD Million)
Table 56 Canada: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 57 Canada: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 58 Canada: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 59 Canada: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 60 Canada: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 61 Canada: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 62 Europe: Market, By Country, 20162023 (USD Million)
Table 63 Europe: Market, By Application, 20162023 (USD Million)
Table 64 Europe: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 65 Europe: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 66 Europe: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 67 Europe: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 68 Europe: Components Market, By Type, 20162023 (USD Million)
Table 69 Europe: Components Market, By Material, 20162023 (USD Million)
Table 70 Germany: Market, By Application, 20162023 (USD Million)
Table 71 Germany: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 72 Germany: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 73 Germany: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 74 Germany: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 75 Germany: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 76 Germany: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 77 France: Market, By Application, 20162023 (USD Million)
Table 78 France: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 79 France: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 80 France: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 81 France: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 82 France: Components Market, By Type, 20162023 (USD Million)
Table 83 France: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 84 UK: Market, By Application, 20162023 (USD Million)
Table 85 UK: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 86 UK: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 87 UK: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 88 UK: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 89 UK: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 90 UK: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 91 Italy: Market, By Application, 20162023 (USD Million)
Table 92 Italy: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 93 Italy: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 94 Italy: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 95 Italy: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 96 Italy: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 97 Italy: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 98 Spain: Market, By Application, 20162023 (USD Million)
Table 99 Spain: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 100 Spain: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 101 Spain: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 102 Spain: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 103 Spain: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 104 Spain: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 105 Rest of Europe: Market, By Application, 20162023 (USD Million)
Table 106 Rest of Europe: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 107 Rest of Europe: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 108 Rest of Europe: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 109 Rest of Europe: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 110 Rest of Europe: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 111 Rest of Europe: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 112 Asia Pacific: Market, By Country, 20162023 (USD Million)
Table 113 Asia Pacific: Market, By Application, 20162023 (USD Million)
Table 114 Asia Pacific: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 115 Asia Pacific: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 116 Asia Pacific: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 117 Asia Pacific: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 118 Asia Pacific: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 119 Asia Pacific: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 120 Japan: Market, By Application, 20162023 (USD Million)
Table 121 Japan: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 122 Japan: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 123 Japan: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 124 Japan: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 125 Japan: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 126 Japan: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 127 China: Microfluidics Market, By Application, 20162023 (USD Million)
Table 128 China: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 129 China: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 130 China: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 131 China: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 132 China: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 133 China: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 134 India: Microfluidics Market, By Application, 20162023 (USD Million)
Table 135 India: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 136 India: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 137 India: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 138 India: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 139 India: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 140 India: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 141 Rest of Asia Pacific: Microfluidics Market, By Application, 20162023 (USD Million)
Table 142 Rest of Asia Pacific: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 143 Rest of Asia Pacific: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 144 Rest of Asia Pacific: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 145 Rest of APAC: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 146 Rest of APAC: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 147 Rest of APAC: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 148 Latin America: Microfluidics Market, By Application, 20162023 (USD Million)
Table 149 Latin America: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 150 Latin America: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 151 Latin America: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 152 Latin America: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 153 Latin America: Microfluidics Components Market, By Type, 20162023 (USD Million)
Table 154 Latin America: Microfluidics Components Market, By Material, 20162023 (USD Million)
Table 155 Middle East & Africa: Microfluidics Market, By Application, 20162023 (USD Million)
Table 156 Middle East & Africa: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 157 Middle East & Africa: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 158 Middle East & Africa: Microfluidics Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 159 Middle East & Africa: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 160 Middle East & Africa: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 161 Middle East & Africa: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 162 Product Portfolio Analysis of Major Players in the Market
Table 163 Product Launches
Table 164 Partnerships, Agreements, and Collaborations
Table 165 Acquisitions
Table 166 Expansions
List of Figures (51 Figures)
Figure 1 Research Design
Figure 2 Primary Sources
Figure 3 Breakdown of Primary Interviews (Supply Side)
Figure 4 Breakdown of Primary Interviews (Demand Side)
Figure 5 Data Triangulation Methodology
Figure 6 in Vitro Diagnostics Application Segment to Witness Highest Growth in the Microfluidics Market
Figure 7 Point-Of-Care Segment Accounted for the Largest Share in 2017
Figure 8 Polymer-Based MicrofluidicsThe Largest Segment of the Microfluidic Components Market, By Material
Figure 9 Microfluidic Chips to Dominate the Microfluidic Components Market, By Type
Figure 10 Geographic Analysis: Global Market, 2017
Figure 11 Rising Demand for Point-Of-Care Testing is Driving the Growth of the Global Microfluidics Market
Figure 12 Japan Accounted for the Largest Share of the Asia Pacific Microfluidic Components Market in 2017
Figure 13 US Accounted for the Largest Share of the Market in 2017
Figure 14 North America is Projected to Dominate the Market During the Forecast Period
Figure 15 High Growth Opportunity in Both Developing and Developed Markets During the Forecast Period
Figure 16 Microfluidics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Market Players Shifting Toward the Adoption of Polymers
Figure 18 Proteomics and Genomics Segments to Register the Highest CAGRs By 2023
Figure 19 in Vitro Diagnostics: Market Snapshot
Figure 20 Point-Of-Care Diagnostics: Market Snapshot
Figure 21 Proteomics: Market Snapshot
Figure 22 Genomics: Market Snapshot
Figure 23 Capillary Electrophoresis Systems: Market Snapshot
Figure 24 Value Chain Analysis
Figure 25 Market, By Application, 2018 vs 2023 (USD Million)
Figure 26 Point-Of-Care Testing Segment to Register the Highest CAGR During the Forecast Period
Figure 27 Lab Analytics Accounted for the Largest Share in the Global Market for Pharmaceutical and Life Science Research in 2017
Figure 28 Microfluidics Market for Lab Analytics, By Type, 2018 vs 2023 (USD Million)
Figure 29 Microfluidics Market for Laboratory Testing, By Type, 2018 vs 2023 (USD Million)
Figure 30 Microfluidic Chips Segment to Dominate the Microfluidic Components Market, By Type, During the Forecast Period
Figure 31 Polymer-Based Microfluidics Segment to Dominate the Microfluidic Components Market, By Material, During the Forecast Period
Figure 32 China & India are Expected to Register the Highest Growth Rates in Microfluidics Market During the Forecast Period
Figure 33 North America: Market Snapshot
Figure 34 Europe: Market Snapshot
Figure 35 Asia Pacific: Market Snapshot
Figure 36 Key Developments in the Market (2015 to 2018)
Figure 37 Growth Strategy Matrix (2015 2018)
Figure 38 Comparative Assessment of Key Players for R&D Expenditure (2017)
Figure 39 Competitive Assessment of Key Players in the Geographic Market (2017)
Figure 40 Company Snapshot: Danaher Corporation (2017)
Figure 41 Company Snapshot: Thermo Fisher Scientific (2017)
Figure 42 Perkinelmer: Company Snapshot (2017)
Figure 43 Company Snapshot: Agilent Technologies (2017)
Figure 44 Company Snapshot: Bio-Rad Laboratories (2017)
Figure 45 BD: Company Snapshot (2017)
Figure 46 Illumina: Company Snapshot (2017)
Figure 47 F. Hoffmann-La Roche Ltd.: Company Snapshot (2017)
Figure 48 Fluidigm Corporation: Company Snapshot (2017)
Figure 49 Qiagen: Company Snapshot (2016)
Figure 50 Abbott: Company Snapshot (2017)
Figure 51 Biomιrieux: Company Snapshot (2017)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Microfluidics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Microfluidics Market